Gabrielle Smith

1 month ago | pm360online.com | Gabrielle Smith

Building on a successful inaugural year, the initiative sponsored byAstellas’ Patient Centricity team continues to connect individuals withvital resources and support from patient advocacy organizations,  /PRNewswire/ — Astellas Patient Centricity is pleased to announce the second annual Patient Advocacy Organization (PAO) Action Week™ taking place June 9-13, 2025.

Mar 24, 2025 | pm360online.com | Gabrielle Smith

How do you build solid analytics learning culture at Fortune 100 companies? Xingchu: Analytics learning culture starts with analytics, and building a data analytics-first culture is critical. This approach means that for every business decision, we start from data and insights, which enables a fact-based conversation. This mindset goes from daily work with each team member to senior business executives.

Feb 17, 2025 | pm360online.com | Gabrielle Smith

DISCOVERIES AND INNOVATIONSNew AI Technology from Addison Whitney Assists with Pharmaceutical Brand NamingAddison Whitney, powered by Syneos Health—a leader in global brand design—proudly announces the launch of Ari™, the pharmaceutical industry’s first AI-driven naming platform. Designed to address the growing complexities of regulatory and legal naming requirements, Ari represents a transformative leap forward in pharmaceutical brand naming.

Dec 20, 2024 | pm360online.com | Gabrielle Smith

Efficacy Results for Beam Therapeutic’s Cell Therapy in Expanded SCD Holds SteadyIn November, Beam Therapeutics shared preliminary data from four sickle-cell disease (SCD) patients in the Phase I/II BEACON trial of its investigational base editing therapy BEAM-101. The company has now expanded its dataset to seven participants, with results presented at the American Society of Hematology (ASH) annual meeting this weekend similar to their earlier findings.

Dec 10, 2024 | pm360online.com | Gabrielle Smith

,  /PRNewswire/ — Omnicom (NYSE: OMC) and The Interpublic Group of Companies, Inc. (NYSE: IPG) (“Interpublic”) today announced their Boards of Directors have unanimously approved a definitive agreement pursuant to which Omnicom will acquire Interpublic in a stock-for-stock transaction. The combined company will bring together the industry’s deepest bench of marketing talent, and the broadest and most innovative services and products, driven by the most advanced sales and marketing platform.